Board of Pharmacy; regulation of psilocybin. Directs the Board of Pharmacy to reschedule psilocybin consistent with federal scheduling upon approval by the U.S. Food and Drug Administration of a formulation of psilocybin designed to be administered by a health care professional in a health care setting. This bill is identical to HB 1347.
2026/04/06 Acts of Assembly Chapter text (CHAP0306)
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | VA SB212 | 0 | 5.62 | 13-04-2026 |
| 2 | MN HF2906 | 0 | 11.45 | 22-04-2026 |
| 3 | VA SB378 | 0 | 4.46 | 14-05-2026 |
| 4 | VA SB199 | 0 | 6.34 | 20-05-2026 |
| 5 | VA SB637 | 0 | 8.09 | 13-04-2026 |
| 6 | VA SB373 | 0 | 3.34 | 13-04-2026 |
| 7 | VA SB74 | 0 | 7.34 | 08-04-2026 |
| 8 | NH HB1249 | 0 | 23.54 | 08-05-2026 |
| 9 | US SB5139 | 0 | 12.39 | 27-07-2026 |